Kyte Group
@GroupKyte
ID:1196728300875501568
https://www.ous-research.no/kyte/ 19-11-2019 09:54:36
66 Tweets
200 Followers
66 Following
On February 9th, Andreas Hagen Røssevold triumphantly completed his Ph.D. defense on 'Immunotherapy and immunological biomarkers in breast cancer' at the OUH. For more details on his groundbreaking research, read his recent publications on Nature Medicine and Journal for ImmunoTherapy of Cancer.
Congratulations to Andreas Røssevold MD, PhD with his fantastic PhD defence and discussion over the outcomes of the Alice snd Icon trials Kyte Group UiO - Det medisinske fakultet RESCUER
Excited to announce our pioneer ICON clinical trial study published in Journal for ImmunoTherapy of Cancer. Thanks to our patients, collaborators, and funders (BMS, Health Region South East, Pink Ribbon/Norwegian Cancer Society). #MATRIX #Oncodistinct #JulesBordet jitc.bmj.com/content/12/1/e…
Åslaug Helland fikk i dag overrakt Kong Olav´s kreftforskningspris av Kong Harald i Universitetets Aula. Gratulerer, Åslaug - vel fortjent!
Åslaug Helland
International Day of Immunology!
Jon Amund Kyte giving a talk about immunotherapy against breast cancer at the Norwegian Society for Immunology (NSI).
Jon Amund Kyte Norwegian Society for Immunology
Congratulations to Professor Åslaug Helland with King Olav V's Prize for Cancer Research!!
Very well deserved! We look forward to working together with Åslaug to further advance cancer research, within and beyond the new national center MATRIX.
Åslaug Helland
In patients with metastatic triple-negative #BreastCancer , atezolizumab + anthracycline-based chemotherapy improves progression-free survival, including in PD-L1 negative disease #SABCS22 Andreas H. Røssevold Kyte Group Jon Amund Kyte Oslounivsykehus UiO - Det medisinske fakultet #BCsm nature.com/articles/s4159…